EMD Millipore, the Life Science division of Merck KGaA, and the Centre for Commercialization of Regenerative Medicine (CCRM) have entered a collaboration to develop optimized conditions for bioreactor-based cultivation of stem cells. The project will focus on the development of a monitoring and control methodology, enabling robust growth of adherent human pluripotent stem cells in EMD Millipore’s Mobius CellReady stirred tank bioreactor. The goal of the project is to deliver a commerciall...